Wells Fargo Response to New York City Mayor Adams and Comptroller Lander
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE:WFC) today issued the following statement responding to New…
News
Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”),…
Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
– SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies in aggressive…
Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Preclinical data demonstrated POC with robust in vitro and in vivo anti-tumor activity UCART20x22 allogeneic…
Kinnate Biopharma Inc. Highlights Data from its Lead RAF Candidate, KIN-2787, and RAF Clinico-Genomics Landscape Studies at the American Association for Cancer Research Annual Meeting
Three poster presentations highlight the unmet need for targeted therapies in BRAF and/or NRAS-altered cancers,…
IO Biotech Announces Presentation of New Data from MM1636 Phase 1/2 Clinical Trial Presented at 2022 AACR Annual Meeting
Updated Data as of December 1, 2021 from Phase 1/2 study of IO102-IO103 in Combination…
Binemon NFT Announces Strategic Partnership with Cronos Chain
The Binemon team is pleased to announce its strategic partnership with Cronos Chain. Los Angeles,…
LBank Exchange Listed Ecowatt (EWT) on April 7, 2022
Internet City, Dubai–(Newsfile Corp. – April 8, 2022) – LBank Exchange, a global digital asset…
Natuzzi S.p.A.:Â Shareholder Letter and Financial Results
2021 – FOURTH QUARTER AND FISCAL YEAR RESULTS FOURTH QUARTER 2021 HIGHLIGHTS INVOICED SALES INCREASED…
Medical Fish-Skin Company Kerecis Introduces MariGen Expanse at the SAWC Conference
An economic solution for large wounds treated in the out-patient care setting PHOENIX–(BUSINESS WIRE)–#SAWC–Kerecis®, the…
First Bancorp to Announce 1Q 2022 Results on April 28, 2022
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–First BanCorp (the “Corporation”) (NYSE: FBP), the bank holding company for…
BlackRock TCP Capital Corp. to Report First Quarter 2022 Financial Results on May 4, 2022
SANTA MONICA, Calif.–(BUSINESS WIRE)–BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will report…
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Highlights
Highlights Include Company’s Progress in the Following Areas: Advances in the Research, Development, and Manufacturing…
Negro Leagues Baseball Museum and First Business Bank Announce Partnership to Help “Coin the Legacy” of the Negro Leagues
The partnership includes designation as the “Official Bank” of the first-ever United States Mint Negro…
Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022
OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation…
Orchid Island Capital to Announce First Quarter 2022 Results
VERO BEACH, Fla.–(BUSINESS WIRE)–Orchid Island Capital, Inc. (NYSE:ORC) (“Orchid” or the “Company”), a real estate…
Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at AACR Annual Meeting 2022
SOUTH SAN FRANCISCO, Calif., April 08, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Coherus and Junshi Biosciences Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting
– Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and…
Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors
The recommended phase 2 dose was determined at 480 mg AFM24 has demonstrated a well-managed…
Aadi Bioscience Announces Data Presentation on incidence of TSC1 and TSC2 Alterations in Advanced Cancers at the Annual Meeting of the American Association for Cancer Research (AACR)
– First rigorous analysis estimates TSC1 and TSC2 definite impact alteration incidence in U.S. as…